Revisiting visual dysfunctions in schizophrenia from the retina to the cortical cells: A manifestation of defective neurodevelopment

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 62, Issue , 2015, Pages 29-34

  Gagné, Anne Marie ^a   Hébert, Marc ^a,b   Maziade, Michel ^a  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Neurodevelopment; Retina; Schizophrenia; Visual system

Indexed keywords

RETINOIC ACID; RETINOL;

BRAIN CELL; COGNITION; DEVELOPMENTAL DISORDER; ELECTRORETINOGRAPHY; EYE TRACKING; HUMAN; NEUROLOGIC DISEASE; NONHUMAN; OPTIC TRACT; OSCILLATORY POTENTIAL; PREGNANCY; PROTEIN FUNCTION; RETINA; RETINAL NERVE FIBER LAYER THICKNESS; REVIEW; SCHIZOPHRENIA; VISUAL CORTEX; VISUAL DISORDER; VISUAL SYSTEM FUNCTION; BRAIN; GROWTH, DEVELOPMENT AND AGING; PATHOPHYSIOLOGY; VISUAL SYSTEM;

BRAIN; HUMANS; RETINA; SCHIZOPHRENIA; VISION DISORDERS; VISUAL PATHWAYS;

EID: 84929346581     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2015.04.007     Document Type: Review

References (84)

1. Ardekani B.A., Nierenberg J., Hoptman M.J., Javitt D.C., Lim K.O. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport 2003, 14:2025-2029.
2. Arend I., Machado L., Ward R., McGrath M., Ro T., Rafal R.D. The role of the human pulvinar in visual attention and action: evidence from temporal-order judgment, saccade decision, and antisaccade tasks. Prog Brain Res 2008, 171:475-483.
3. Arfaoui A., Lobo M.V., Boulbaroud S., Ouichou A., Mesfioui A., Arenas M.I. Expression of retinoic acid receptors and retinoid X receptors in normal and vitamin A deficient adult rat brain. Ann Anat 2013, 195:111-121.
4. Balogh Z., Benedek G., Keri S. Retinal dysfunctions in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:297-300.
5. Bao Y., Ibram G., Blaner W.S., Quesenberry C.P., Shen L., McKeague I.W., et al. Low maternal retinol as a risk factor for schizophrenia in adult offspring. Schizophr Res 2012, 137:159-165.
6. Bartfai A., Levander S.E., Nyback H., Berggren B.M., Schalling D. Smooth pursuit eye tracking, neuropsychological test performance, and computed tomography in schizophrenia. Psychiatry Res 1985, 15:49-62.
7. Bear M.F., Connors B.W., Paradiso M.A., Nieoullon A. Neurosciences à la découverte du cerveau trad. et adapt. française, André Nieoullon 1999, Rueil-Malmaison, Pradel.
8. Boyce P.R. Human factor in lighting 2003, Taylor & Françis, New York. 2nd ed.
9. Brown K.T. The eclectroretinogram: its components and their origins. Vision Res 1968, 8:633-677.
10. Buchsbaum M.S., Nenadic I., Hazlett E.A., Spiegel-Cohen J., Fleischman M.B., Akhavan A., et al. Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res 2002, 54:141-150.
11. Buchsbaum M.S., Buchsbaum B.R., Hazlett E.A., Haznedar M.M., Newmark R., Tang C.Y., et al. Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry 2007, 164:1072-1081.
12. Butler P.D., Hoptman M.J., Nierenberg J., Foxe J.J., Javitt D.C., Lim K.O. Visual white matter integrity in schizophrenia. Am J Psychiatry 2006, 163:2011-2013.
13. Byne W., Buchsbaum M.S., Mattiace L.A., Hazlett E.A., Kemether E., Elhakem S.L., et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry 2002, 159:59-65.
14. Byne W., Fernandes J., Haroutunian V., Huacon D., Kidkardnee S., Kim J., et al. Reduction of right medial pulvinar volume and neuron number in schizophrenia. Schizophr Res 2007, 90:71-75.
15. Chu E.M., Kolappan M., Barnes T.R., Joyce E.M., Ron M.A. A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography. Psychiatry Res 2012, 203:89-94.
16. Cohen M. Ocular findings in 323 patients with schizophrenia; a preliminary report. Arch Ophthalmol 1949, 41:697-700.
17. Conlon R.A. Retinoic acid and pattern formation in vertebrates. Trends Genet 1995, 11:314-319.
18. Danziger S., Ward R., Owen V., Rafal R. Contributions of the human pulvinar to linking vision and action. Cogn Affect Behav Neurosci 2004, 4:89-99.
19. Davies G., Welham J., Chant D., Torrey E.F., McGrath J. A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr Bull 2003, 29:587-593.
20. Demler T.L. Challenging the hypothesized link to season of birth in patients with schizophrenia. Innov Clin Neurosci 2011, 8:14-19.
21. Desco M., Gispert J.D., Reig S., Sanz J., Pascau J., Sarramea F., et al. Cerebral metabolic patterns in chronic and recent-onset schizophrenia. Psychiatry Res 2003, 122:125-135.
22. Dong C.J., Agey P., Hare W.A. Origins of the electroretinogram oscillatory potentials in the rabbit retina. Vis Neurosci 2004, 21:533-543.
23. Dorph-Petersen K.A., Pierri J.N., Wu Q., Sampson A.R., Lewis D.A. Primary visual cortex volume and total neuron number are reduced in schizophrenia. J Comp Neurol 2007, 501:290-301.
24. Fatemi S.H., Folsom T.D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009, 35:528-548.
25. Foong J., Symms M.R., Barker G.J., Maier M., Woermann F.G., Miller D.H., et al. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain 2001, 124:882-892.
26. Ford J.M., Palzes V.A., Roach B.J., Potkin S.G., van Erp T.G., Turner J.A., et al. Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia. Schizophr Bull 2015, 41:223-232.
27. Forrester J.V. The eye: basic sciences in practice. 2nd ed. Edinburgh 2002, W.B. Saunders, New York.
28. Fukumoto-Motoshita M., Matsuura M., Ohkubo T., Ohkubo H., Kanaka N., Matsushima E., et al. Hyperfrontality in patients with schizophrenia during saccade and antisaccade tasks: a study with fMRI. Psychiatry Clin Neurosci 2009, 63:209-217.
29. Genest A.A., Sarwono D., Gyorgy P. Vitamin A blood serum levels and electroretinogram in 5- to 14-year age group in Indonesia and Thailand. A preliminary report. Am J Clin Nutr 1967, 20:1275-1279.
30. Gerbaldo H., Thaker G., Tittel P.G., Layne-Gedge J., Moran M., Demisch L. Abnormal electroretinography in schizophrenic patients with a history of sun gazing. Neuropsychobiology 1992, 25:99-101.
31. Goldberg J.S. Monitoring maternal Beta carotene and retinol consumption may decrease the incidence of neurodevelopmental disorders in offspring. Clin Med Insights Reprod Health 2011, 6:1-8.
32. Goodman A.B. Congenital anomalies in relatives of schizophrenic probands may indicate a retinoid pathology. Schizophr Res 1996, 19:163-170.
33. Goodman A.B. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci U S A 1998, 95:7240-7244.
34. Green D.G., Kapousta-Bruneau N.V. A dissection of the electroretinogram from the isolated rat retina with microelectrodes and drugs. Vis Neurosci 1999, 16:727-741.
35. Guo Z., Chen L.M., Zeng H., Gomez J.A., Plowden J., Fujita T., et al. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 2007, 36:263-269.
36. Hallett P.E. Primary and secondary saccades to goals defined by instructions. Vision Res 1978, 18:1279-1296.
37. Harada T., Harada C., Parada L.F. Molecular regulation of visual system development: more than meets the eye. Genes Dev 2007, 21:367-378.
38. Hazlett E.A., Buchsbaum M.S., Kemether E., Bloom R., Platholi J., Brickman A.M., et al. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am J Psychiatry 2004, 161:305-314.
39. Hebert M., Gagne A.M., Paradis M.E., Jomphe V., Roy M.A., Merette C., et al. Retinal response to light in young nonaffected offspring at high genetic risk of neuropsychiatric brain disorders. Biol Psychiatry 2010, 67:270-274.
40. Hebert M., Merette C., Paccalet T., Emond C., Gagne A.M., Sasseville A., et al. Light evoked potentials measured by electroretinogram may tap into the neurodevelopmental roots of schizophrenia. Schizophr Res 2015, 162:294-295.
41. Holland L.Z. Developmental biology: a chordate with a difference. Nature 2007, 447:153-155.
42. Holzman P.S., Proctor L.R., Hughes D.W. Eye-tracking patterns in schizophrenia. Science 1973, 181:179-181.
43. Holzman P.S., Proctor L.R., Levy D.L., Yasillo N.J., Meltzer H.Y., Hurt S.W. Eye-tracking dysfunctions in schizophrenic patients and their relatives. Arch Gen Psychiatry 1974, 31:143-151.
44. Hong L.E., Tagamets M., Avila M., Wonodi I., Holcomb H., Thaker G.K. Specific motion processing pathway deficit during eye tracking in schizophrenia: a performance-matched functional magnetic resonance imaging study. Biol Psychiatry 2005, 57:726-732.
45. Insel T.R. Mental disorders in childhood: shifting the focus from behavioral symptoms to neurodevelopmental trajectories. JAMA 2014, 311:1727-1728.
46. Karwoski C.J., Xu X. Current source-density analysis of light-evoked field potentials in rabbit retina. Vis Neurosci 1999, 16:369-377.
47. Kelley M.W., Williams R.C., Turner J.K., Creech-Kraft J.M., Reh T.A. Retinoic acid promotes rod photoreceptor differentiation in rat retina in vivo. Neuroreport 1999, 10:2389-2394.
48. Kemether E.M., Buchsbaum M.S., Byne W., Hazlett E.A., Haznedar M., Brickman A.M., et al. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch Gen Psychiatry 2003, 60:983-991.
49. Kinney D.K., Levy D.L., Yurgelun-Todd D.A., Lajonchere C.M., Holzman P.S. Eye-tracking dysfunction and birth-month weather in schizophrenia. J Abnorm Psychol 1999, 108:359-362.
50. Kinney D.K., Jacobsen B., Jansson L., Faber B., Tramer S.J., Suozzo M. Winter birth and biological family history in adopted schizophrenics. Schizophr Res 2000, 44:95-103.
51. Lee K.H., Williams L.M. Eye movement dysfunction as a biological marker of risk for schizophrenia. Aust N Z J Psychiatry 2000, 34(Suppl.):S91-S100.
52. Lee W.W., Tajunisah I., Sharmilla K., Peyman M., Subrayan V. Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography. Invest Ophthalmol Vis Sci 2013, 54:7785-7792.
53. Lencer R., Malchow C.P., Trillenberg-Krecker K., Schwinger E., Arolt V. Eye-tracking dysfunction (ETD) in families with sporadic and familial schizophrenia. Biol Psychiatry 2000, 47:391-401.
54. Lencer R., Nagel M., Sprenger A., Heide W., Binkofski F. Reduced neuronal activity in the V5 complex underlies smooth-pursuit deficit in schizophrenia: evidence from an fMRI study. Neuroimage 2005, 24:1256-1259.
55. Lesch A., Bogerts B. The diencephalon in schizophrenia: evidence for reduced thickness of the periventricular grey matter. European archives of psychiatry and neurological sciences. 1984, 234:212-219.
56. Leung A., Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000, 401:3-38.
57. Levy D.L., Holzman P.S., Matthysse S., Mendell N.R. Eye tracking dysfunction and schizophrenia: a critical perspective. Schizophr Bull 1993, 19:461-536.
58. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002, 25:409-432.
59. Luck S.J., Gold J.M. The construct of attention in schizophrenia. Biol Psychiatry 2008, 64:34-39.
60. Maden M., Sonneveld E., van der Saag P.T., Gale E. The distribution of endogenous retinoic acid in the chick embryo: implications for developmental mechanisms. Development 1998, 125:4133-4144. (Cambridge, England).
61. Mai J.K., Paxinos G. The human nervous system 2012, Elsevier Academic Press, Amsterdam ; Boston. 3rd ed.
62. Masland R.H. The fundamental plan of the retina. Nat Neurosci 2001, 4:877-886.
63. Maziade M., Rouleau N., Cellard C., Battaglia M., Paccalet T., Moreau I., et al. Young Offspring at Genetic Risk of Adult Psychoses: The Form of the Trajectory of IQ or Memory May Orient to the Right Dysfunction at the Right Time. PLoS One 2011, 6:e19153.
64. McGrath J.J., Eyles D.W., Pedersen C.B., Anderson C., Ko P., Burne T.H., et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch Gen Psychiatry 2010, 67:889-894.
65. Meier M.H., Shalev I., Moffitt T.E., Kapur S., Keefe R.S., Wong T.Y., et al. Microvascular abnormality in schizophrenia as shown by retinal imaging. Am J Psychiatry 2013, 170:1451-1459.
66. Mitelman S.A., Byne W., Kemether E.M., Hazlett E.A., Buchsbaum M.S. Correlations between volumes of the pulvinar, centromedian, and mediodorsal nuclei and cortical Brodmann's areas in schizophrenia. Neurosci Lett 2006, 392:16-21.
67. Narr K.L., Toga A.W., Szeszko P., Thompson P.M., Woods R.P., Robinson D., et al. Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol Psychiatry 2005, 58:32-40.
68. O'Driscoll G.A., Callahan B.L. Smooth pursuit in schizophrenia: a meta-analytic review of research since 1993. Brain Cogn 2008, 68:359-370.
69. Oyster C.W. The Human Eye: Structure and Function 1999, Sinauer Associates, Sunderland. 1st ed.
70. Palha J.A., Goodman A.B. Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia. Brain Res Rev 2006, 51:61-71.
71. Petersen S.E., Robinson D.L., Morris J.D. Contributions of the pulvinar to visual spatial attention. Neuropsychologia 1987, 25:97-105.
72. Raese J., King R., Barnes D., Berger P., Marmor M., Hock P. Retinal oscillatory potentials in schizophrenia: Implications for the assessment of dopamine transmission in man. Pharmacol Bull 1982, 18:72-78.
73. Rapoport J.L., Addington A.M., Frangou S., Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 2005, 10:434-449.
74. Rohde C.M., Manatt M., Clagett-Dame M., DeLuca H.F. Vitamin A antagonizes the action of vitamin D in rats. J Nutr 1999, 129:2246-2250.
75. Schechter G., Hock P., Rodgers K., Pfefferbaum A., Marmor M.F., Berger P.A. Electroretinographic assessment in schizophrenia. Electroencephalogr Clin Neurophysiol Suppl 1987, 40:746-751.
76. Selemon L.D., Begovic A. Stereologic analysis of the lateral geniculate nucleus of the thalamus in normal and schizophrenic subjects. Psychiatry Res 2007, 151:1-10.
77. Silverstein S., Keane B.P., Blake R., Giersch A., Green M., Keri S. Vision in schizophrenia: why it matters. Front Psychol 2015, 6:41.
78. Uranova N.A., Zimina I.S., Vikhreva O.V., Krukov N.O., Rachmanova V.I., Orlovskaya D.D. Ultrastructural damage of capillaries in the neocortex in schizophrenia. World J Biol Psychiatry 2010, 11:567-578.
79. Valipour G., Saneei P., Esmaillzadeh A. Serum Vitamin D Levels in Relation to Schizophrenia: A Systematic Review and Meta-Analysis of Observational Studies. J Clin Endocrinol Metab 2014, jc20141887.
80. Venables P.H., Tizard J. The effect of stimulus light intensity on reaction time of schizophrenics. Br J Psychol 1956, 47:144-147.
81. Wang L., Shi P., Xu Z., Li J., Xie Y., Mitton K., et al. Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy. Invest Ophthalmol Vis Sci 2014, 55:4276-4287.
82. Warner R., Laugharne J., Peet M., Brown L., Rogers N. Retinal function as a marker for cell membrane omega-3 fatty acid depletion in schizophrenia: a pilot study. Biol Psychiatry 1999, 45:1138-1142.
83. Watson J.D., Myers R., Frackowiak R.S., Hajnal J.V., Woods R.P., Mazziotta J.C., et al. Area V5 of the human brain: evidence from a combined study using positron emission tomography and magnetic resonance imaging. Cereb Cortex 1993, 3:79-94.
84. Wickremasinghe S.S., Xie J., Guymer R.H., Wong T.Y., Kawasaki R., Qureshi S. Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period. Eye (Lond) 2012, 26:958-966.